Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease
Abstract Background and aims Intestinal paralysis is a common complication in end-stage liver disease (ESLD), our aim is to assess the effectiveness and safety of low-dose terlipressin for treating intestinal paralysis in ESLD. Methods The study was divided into two phases, in the exploratory phase,...
Saved in:
| Main Authors: | Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Gastroenterology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12876-025-03910-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyponatraemia Induced by Terlipressin in Patients Diagnosed with Decompensated Liver Cirrhosis and Acute Variceal Bleeding
by: Mahmoud Elshehawy, et al.
Published: (2025-03-01) -
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging
by: Karen Vagner Danielsen, et al.
Published: (2025-08-01) -
Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report
by: Quanyao Chen, et al.
Published: (2020-08-01) -
Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial
by: Valeria Perez-Campuzano, et al.
Published: (2025-04-01) -
Terlipressin at esophageal varicose bleeding at liver cirrhosis with portal hypertension syndrome
by: B. N. Kotiv, et al.
Published: (2013-10-01)